United States Pharmaceuticals

Vitae Pharmaceuticals LLC (VTAE)

Track

Ticker: VTAE Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 14 Sep 2016
Value US$2,935,598.81 | Price 177.03 | Shares 88,565 (-49.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-09-16 2016-09-14 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
88,565 -49.7%
177.03
US$2,935,599 		88,565 -49.7% 177.03 US$2,935,599
2016-09-16 2016-09-14 PlS Planned sale Hatfield Jeffrey S.

Chief Executive Officer

Executive Director
63,540 +14.0%
136.14
US$3,243,215 		63,540 +14.0% 136.14 US$3,243,215
2016-03-21 2016-03-21 PlS Planned sale HAYDEN DONALD J JR Non-Executive Director
78,940 +7.4%
270.66
US$778,525 		78,940 +7.4% 270.66 US$778,525
2015-12-30 2015-12-29 PlS Planned sale HAYDEN DONALD J JR Non-Executive Director
16,130 -100.0%
18.00
US$290,340 		16,130 -100.0% 18.00 US$290,340
2015-12-28 2015-12-23 PlS Planned sale Hatfield Jeffrey S.

Chief Executive Officer

Executive Director
22,524 -7.8%
17.00
US$382,908 		22,524 -7.8% 17.00 US$382,908
2015-09-22 2015-09-21 PlS Planned sale HAYDEN DONALD J JR Non-Executive Director
16,130 -100.0%
17.00
US$274,210 		16,130 -100.0% 17.00 US$274,210
2015-08-31 2015-08-27 B Purchase Fratamico Arthur

Chief Business Officer

Officer
10,000 +inf%
7.83
US$78,266 		10,000 +inf% 7.83 US$78,266
2015-05-22 2015-05-20 S Sale HAYDEN DONALD J JR Non-Executive Director
20,000 -100.0%
12.01
US$240,200 		20,000 -100.0% 12.01 US$240,200
2014-10-01 2014-09-29 B Purchase PROSPECT MANAGEMENT CO II LLC Large shareholder
671,807 +35.3%
8.00
US$5,374,456 		671,807 +35.3% 8.00 US$5,374,456
2014-10-01 2014-09-29 B Purchase VENROCK MANAGEMENT III LLC Large shareholder
15,446 +48.8%
8.00
US$123,568 		15,446 +48.8% 8.00 US$123,568
2014-10-01 2014-09-29 B Purchase VENROCK MANAGEMENT III LLC Large shareholder
617,868 +48.8%
8.00
US$4,942,944 		617,868 +48.8% 8.00 US$4,942,944
2014-10-01 2014-09-29 B Purchase VENROCK MANAGEMENT III LLC Large shareholder
139,019 +48.8%
8.00
US$1,112,152 		139,019 +48.8% 8.00 US$1,112,152
2014-10-01 2014-09-29 B Purchase ROBERTS BRYAN E Non-Executive Director Large shareholder
15,446 +48.8%
8.00
US$123,568 		15,446 +48.8% 8.00 US$123,568
2014-10-01 2014-09-29 B Purchase ROBERTS BRYAN E Non-Executive Director Large shareholder
617,868 +48.8%
8.00
US$4,942,944 		617,868 +48.8% 8.00 US$4,942,944
2014-10-01 2014-09-29 B Purchase ROBERTS BRYAN E Non-Executive Director Large shareholder
139,019 +48.8%
8.00
US$1,112,152 		139,019 +48.8% 8.00 US$1,112,152
2014-10-01 2014-09-29 B Purchase NEW ENTERPRISE ASSOCIATES 10 L P Large shareholder
813,474 +45.2%
8.00
US$6,507,792 		813,474 +45.2% 8.00 US$6,507,792
2014-10-01 2014-09-29 B Purchase Barrett Peter Non-Executive Director
37,500 +3.3%
8.00
US$300,000 		37,500 +3.3% 8.00 US$300,000
Explore more

More insider trading research around Vitae Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America